Glyphosate — ICAN Poll: Overwhelming Majority of Respondents Oppose Glyphosate Stockpiling, Reject Manufacturer Immunity. New public opinion data from 2,569 respondents reveals near-unanimous opposition to key provisions of the administration’s glyphosate executive order By ICAN (04/03/26)
These results speak for themselves. The American public is paying attention. They know about the billions in legal judgments. They know the key safety study has been retracted. — Del Bigtree, founder and CEO of ICAN
Informed Consent Action Network polled 2,569 respondents among their audience. The result: overwhelming opposition to federal stockpiling of glyphosate-based herbicides and rejection of legal immunity for manufacturers.
Key Poll Findings
95.6% aware glyphosate-based herbicides are linked to more than $10 billion in cancer-related jury verdicts and settlements.
89.0% oppose federal stockpiling of glyphosate-based herbicides.
97.8% oppose legal immunity for manufacturers of glyphosate-based herbicides.
80.2% say November 2025 retraction of a foundational safety study affected trust in glyphosate safety claims.
Poll Context
Poll conducted after…
Trump Administration’s executive order directing federal agencies to stockpile glyphosate-based herbicides for national preparedness planning.
Bayer AG paid more than $10 billion in verdicts and settlements over claims its Roundup herbicide causes non-Hodgkin’s lymphoma and faces approximately 67,000 active lawsuits.
Study in Regulatory Toxicology and Pharmacology was retracted November 28, 2025.
Conducted online in February 2026 via ICAN’s email list, website, and social media.
Included four multiple-choice questions with Yes/No/Unsure options.
Not a statistically representative sample of the U.S. population, but a strong referendum among people who are informed about glyphosate.
Mar 11
at
8:35 PM
Relevant people
Log in or sign up
Join the most interesting and insightful discussions.